Literature DB >> 27814603

Gene therapy using bacterial vectors.

Peter Celec1, Roman Gardlik2.   

Abstract

Bacteria can be used for gene therapy via two strategies - either by transfection of eukaryotic host cells using bacteria (bactofection) or by alternative gene therapy that does not alter the host genome, but uses the prokaryotic expression system, which can be controlled or stopped from outside. While bactofection is optimal for gene substitution and DNA vaccination, alternative gene therapy is suitable for in situ delivery of proteins and treatment with intracellular bactochondria. A specific form of bacteria-mediated gene therapy is transkingdom RNA interference. In this review, advantages and issues related to bacterial vectors as well as the major applications in biomedical research are summarized. Despite numerous published experiments, especially in the treatment of solid tumors and gut infections, progress in the clinics lags behind and major improvements in the safety, and even more in the efficiency, of these approaches are needed.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 27814603     DOI: 10.2741/4473

Source DB:  PubMed          Journal:  Front Biosci (Landmark Ed)        ISSN: 2768-6698


  6 in total

1.  PD-1 siRNA-Encapsulated Solid Lipid Nanoparticles Downregulate PD-1 Expression by Macrophages and Inhibit Tumor Growth : PD-1 siRNA-Encapsulated Solid Lipid Nanoparticles.

Authors:  Mahmoud S Hanafy; Stephanie Hufnagel; Andrea N Trementozzi; Wedad Sakran; Jeanne C Stachowiak; John J Koleng; Zhengrong Cui
Journal:  AAPS PharmSciTech       Date:  2021-01-31       Impact factor: 3.246

2.  Metabolomics Analysis of Viral Therapeutics.

Authors:  Haiwei Gu; Xiaojian Shi; Paniz Jasbi; Jeffrey Patterson
Journal:  Methods Mol Biol       Date:  2021

3.  DNA Delivery and Genomic Integration into Mammalian Target Cells through Type IV A and B Secretion Systems of Human Pathogens.

Authors:  Dolores L Guzmán-Herrador; Samuel Steiner; Anabel Alperi; Coral González-Prieto; Craig R Roy; Matxalen Llosa
Journal:  Front Microbiol       Date:  2017-08-22       Impact factor: 5.640

Review 4.  Live Bacterial Vectors-A Promising DNA Vaccine Delivery System.

Authors:  Valentina Yurina
Journal:  Med Sci (Basel)       Date:  2018-03-23

Review 5.  DNA Vaccines-How Far From Clinical Use?

Authors:  Dominika Hobernik; Matthias Bros
Journal:  Int J Mol Sci       Date:  2018-11-15       Impact factor: 5.923

6.  Safety, tolerability and immunogenicity of V934/V935 hTERT vaccination in cancer patients with selected solid tumors: a phase I study.

Authors:  Luigi Aurisicchio; Arthur Fridman; David Mauro; Rose Sheloditna; Alberto Chiappori; Ansuman Bagchi; Gennaro Ciliberto
Journal:  J Transl Med       Date:  2020-01-30       Impact factor: 5.531

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.